Mindmed and bioxcel therapeutics publish an international patent application describing a system for identifying agitation episodes

New york, sept. 2, 2021 /prnewswire/ -- mindmed (nasdaq: mnmd) (neo: mmed) (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, and bioxcel therapeutics, inc. ("bioxcel"), a leading clinical-stage biopharmaceutical company, announce the publication of bioxcel's international patent application no.
MNMD Ratings Summary
MNMD Quant Ranking